Sagacity in antibody humanization for therapeutics, diagnostics and research purposes: considerations of antibody elements and their roles

WL Ling, WH Lua, SKE Gan - Antibody Therapeutics, 2020 - academic.oup.com
The humanization of antibodies for therapeutics is a critical process that can determine the
success of antibody drug development. However, the science underpinning this process …

Sagacious epitope selection for vaccines, and both antibody-based therapeutics and diagnostics: tips from virology and oncology

SKE Gan, SX Phua, JY Yeo - Antibody Therapeutics, 2022 - academic.oup.com
The target of an antibody plays a significant role in the success of antibody-based
therapeutics and diagnostics, and vaccine development. This importance is focused on the …

Not all therapeutic antibody isotypes are equal: the case of IgM versus IgG in Pertuzumab and Trastuzumab

F Samsudin, JY Yeo, SKE Gan, PJ Bond - Chemical science, 2020 - pubs.rsc.org
The therapeutic potential of immunoglobulin M (IgM) is of considerable interest in
immunotherapy due to its complement-activating and cell-agglutinating abilities …

Molecular insights of nickel binding to therapeutic antibodies as a possible new antibody superantigen

CTT Su, WH Lua, JJ Poh, WL Ling, JY Yeo… - Frontiers in …, 2021 - frontiersin.org
The binding of nickel by immune proteins can manifest as Type IV contact dermatitis (Ni-
specific T cells mediated) and less frequently as Type I hypersensitivity with both …

[HTML][HTML] Role of the IgE variable heavy chain in FcεRIα and superantigen binding in allergy and immunotherapy

WH Lua, CTT Su, JY Yeo, JJ Poh, WL Ling… - Journal of Allergy and …, 2019 - Elsevier
Background Variable heavy chain (VH) family frameworks (FWRs) have been reported to
affect antibody receptor and superantigen binding; however, such effects in IgE remain …

Reviewing HIV-1 Gag mutations in protease inhibitors resistance: insights for possible novel Gag inhibitor designs

CTT Su, DWS Koh, SKE Gan - Molecules, 2019 - mdpi.com
HIV protease inhibitors against the viral protease are often hampered by drug resistance
mutations in protease and in the viral substrate Gag. To overcome this drug resistance and …

More than meets the kappa for antibody Superantigen protein L (PpL)

WL Ling, JY Yeo, YL Ng, A Wipat, SKE Gan - Antibodies, 2022 - mdpi.com
Immunoglobulin superantigens play an important role in affinity purification of antibodies
and the microbiota-immune axis at mucosal areas. Based on current understanding …

Essentially leading antibody production: an investigation of amino acids, myeloma, and natural V-region signal peptides in producing Pertuzumab and Trastuzumab …

WL Ling, CTT Su, WH Lua, JJ Poh, YL Ng… - Frontiers in …, 2020 - frontiersin.org
Boosting the production of recombinant therapeutic antibodies is crucial in both academic
and industry settings. In this work, we investigated the usage of varying signal peptides by …

Variable-heavy (VH) families influencing IgA1&2 engagement to the antigen, FcαRI and superantigen proteins G, A, and L

WL Ling, CTT Su, WH Lua, JY Yeo, JJ Poh, YL Ng… - Scientific Reports, 2022 - nature.com
Interest in IgA as an alternative antibody format has increased over the years with much
remaining to be investigated in relation to interactions with immune cells. Considering the …

Augmenting recombinant antibody production in HEK293E cells: optimizing transfection and culture parameters

ZSL Heng, JY Yeo, DWS Koh, SKE Gan… - Antibody …, 2022 - academic.oup.com
Background Optimizing recombinant antibody production is important for cost-effective
therapeutics and diagnostics. With impact on commercialization, higher productivity beyond …